Chronic myeloid leukemia, or CML, is a blood cancer that's defined by a specific genetic change. Doctors have been using drugs that target this change, called tyrosine kinase inhibitors, to treat CML. These drugs have been a game-changer, but some patients don't respond well and their condition worsens. Now, scientists are looking deeper into the DNA of CML cells. Th...

Cancer is a complex disease. It can be hard to treat. But, there is a new tool in the fight against cancer. It is called broad genomic profiling. This tool looks at the genes of cancer cells. It helps doctors understand the cancer better. Genomic profiling is not new. But, it is becoming more common. Doctors are using it more often. This is because it can help them ...

Cancer treatment is no longer one-size-fits-all. Genomic profiling, especially comprehensive genomic profiling (CGP), can offer tailored treatments. However, this advanced approach faces several hurdles. Designing studies to test these methods is tough and time-consuming, making the benefits uncertain. The cost and clinical advantages are key factors in deciding whet...